Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Nantong University has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action is being processed within 1 distinct art unit, reflecting a focused area of research for this specific filing. The matter is assigned to 1 distinct examiner, CRAIGO, WILLIAM A, who is the sole individual reviewing the university's current pending workload at the USPTO.
CRAIGO, WILLIAM A is the busiest examiner for the portfolio, as they are responsible for the 1 pending office action. This specific action constitutes the entirety of the university's active prosecution in this sector. The use of 1 distinct art unit suggests a straightforward examination path within a single specialized group. For the university, the success of this current portfolio depends on the specific feedback and requirements of this 1 examiner within that 1 art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CRAIGO, WILLIAM A | 1 | 49.0% | +38.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18684910 | CELL MATRIX NERVE GRAFT FOR REPAIRING PERIPHERAL NERVE INJURY AND PREPARATION METHOD THEREOF | CRAIGO, WILLIAM A | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18684910 | CELL MATRIX NERVE GRAFT FOR REPAIRING PERIPHERAL NERVE INJURY AND PREPARATION METHOD THEREOF | CRAIGO, WILLIAM A | 1615 | §103Other | Final Rejection | — | Pending | Feb 20, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNantong University has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
William A Craigo has the most, with 1 of Nantong University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.